Symptomatic efficacy of rasagiline monotherapy in early Parkinson's disease: post-hoc analyses from the ADAGIO trial.
Identifieur interne : 000055 ( Main/Exploration ); précédent : 000054; suivant : 000056Symptomatic efficacy of rasagiline monotherapy in early Parkinson's disease: post-hoc analyses from the ADAGIO trial.
Auteurs : Joseph Jankovic [États-Unis] ; Elijahu Berkovich [Israël] ; Eli Eyal [Israël] ; Eduardo Tolosa [Espagne]Source :
- Parkinsonism & related disorders ; 2014.
English descriptors
- KwdEn :
- MESH :
- chemical , therapeutic use : Indans, Neuroprotective Agents.
- drug effects : Motor Activity.
- drug therapy : Parkinson Disease.
- physiopathology : Parkinson Disease.
- Cohort Studies, Double-Blind Method, Female, Humans, Male.
Abstract
The ADAGIO study included a large cohort of patients with early PD (baseline total-UPDRS = 20) who were initially randomized to rasagiline and placebo, thereby allowing analyses of symptomatic efficacy.
DOI: 10.1016/j.parkreldis.2014.02.024
PubMed: 24637126
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000030
- to stream PubMed, to step Curation: 000030
- to stream PubMed, to step Checkpoint: 000024
- to stream Ncbi, to step Merge: 000447
- to stream Ncbi, to step Curation: 000447
- to stream Ncbi, to step Checkpoint: 000447
- to stream Main, to step Merge: 000055
- to stream Main, to step Curation: 000055
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Symptomatic efficacy of rasagiline monotherapy in early Parkinson's disease: post-hoc analyses from the ADAGIO trial.</title><author><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name><affiliation wicri:level="2"><nlm:affiliation>Parkinson's Disease Center and Movement Disorders Clinic, Dept of Neurology, Baylor College of Medicine, Houston, TX 77030, USA. Electronic address: josephj@bcm.tmc.edu.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Parkinson's Disease Center and Movement Disorders Clinic, Dept of Neurology, Baylor College of Medicine, Houston, TX 77030</wicri:regionArea><placeName><region type="state">Texas</region></placeName><placeName><settlement type="city">Houston</settlement><region type="state">Texas</region></placeName><orgName type="university" n="3">Baylor College of Medicine</orgName></affiliation></author><author><name sortKey="Berkovich, Elijahu" sort="Berkovich, Elijahu" uniqKey="Berkovich E" first="Elijahu" last="Berkovich">Elijahu Berkovich</name><affiliation wicri:level="1"><nlm:affiliation>Teva Pharmaceutical Industries Ltd, Petach Tikva, Israel.</nlm:affiliation><country xml:lang="fr">Israël</country><wicri:regionArea>Teva Pharmaceutical Industries Ltd, Petach Tikva</wicri:regionArea><wicri:noRegion>Petach Tikva</wicri:noRegion></affiliation></author><author><name sortKey="Eyal, Eli" sort="Eyal, Eli" uniqKey="Eyal E" first="Eli" last="Eyal">Eli Eyal</name><affiliation wicri:level="1"><nlm:affiliation>Teva Pharmaceutical Industries Ltd, Petach Tikva, Israel.</nlm:affiliation><country xml:lang="fr">Israël</country><wicri:regionArea>Teva Pharmaceutical Industries Ltd, Petach Tikva</wicri:regionArea><wicri:noRegion>Petach Tikva</wicri:noRegion></affiliation></author><author><name sortKey="Tolosa, Eduardo" sort="Tolosa, Eduardo" uniqKey="Tolosa E" first="Eduardo" last="Tolosa">Eduardo Tolosa</name><affiliation wicri:level="1"><nlm:affiliation>Neurology Service, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Hospital Clínic, IDIBAPS, Universitat de Barcelona, Catalonia, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Neurology Service, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Hospital Clínic, IDIBAPS, Universitat de Barcelona, Catalonia</wicri:regionArea><wicri:noRegion>Catalonia</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:24637126</idno><idno type="pmid">24637126</idno><idno type="doi">10.1016/j.parkreldis.2014.02.024</idno><idno type="wicri:Area/PubMed/Corpus">000030</idno><idno type="wicri:Area/PubMed/Curation">000030</idno><idno type="wicri:Area/PubMed/Checkpoint">000024</idno><idno type="wicri:Area/Ncbi/Merge">000447</idno><idno type="wicri:Area/Ncbi/Curation">000447</idno><idno type="wicri:Area/Ncbi/Checkpoint">000447</idno><idno type="wicri:Area/Main/Merge">000055</idno><idno type="wicri:Area/Main/Curation">000055</idno><idno type="wicri:Area/Main/Exploration">000055</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Symptomatic efficacy of rasagiline monotherapy in early Parkinson's disease: post-hoc analyses from the ADAGIO trial.</title><author><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name><affiliation wicri:level="2"><nlm:affiliation>Parkinson's Disease Center and Movement Disorders Clinic, Dept of Neurology, Baylor College of Medicine, Houston, TX 77030, USA. Electronic address: josephj@bcm.tmc.edu.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Parkinson's Disease Center and Movement Disorders Clinic, Dept of Neurology, Baylor College of Medicine, Houston, TX 77030</wicri:regionArea><placeName><region type="state">Texas</region></placeName><placeName><settlement type="city">Houston</settlement><region type="state">Texas</region></placeName><orgName type="university" n="3">Baylor College of Medicine</orgName></affiliation></author><author><name sortKey="Berkovich, Elijahu" sort="Berkovich, Elijahu" uniqKey="Berkovich E" first="Elijahu" last="Berkovich">Elijahu Berkovich</name><affiliation wicri:level="1"><nlm:affiliation>Teva Pharmaceutical Industries Ltd, Petach Tikva, Israel.</nlm:affiliation><country xml:lang="fr">Israël</country><wicri:regionArea>Teva Pharmaceutical Industries Ltd, Petach Tikva</wicri:regionArea><wicri:noRegion>Petach Tikva</wicri:noRegion></affiliation></author><author><name sortKey="Eyal, Eli" sort="Eyal, Eli" uniqKey="Eyal E" first="Eli" last="Eyal">Eli Eyal</name><affiliation wicri:level="1"><nlm:affiliation>Teva Pharmaceutical Industries Ltd, Petach Tikva, Israel.</nlm:affiliation><country xml:lang="fr">Israël</country><wicri:regionArea>Teva Pharmaceutical Industries Ltd, Petach Tikva</wicri:regionArea><wicri:noRegion>Petach Tikva</wicri:noRegion></affiliation></author><author><name sortKey="Tolosa, Eduardo" sort="Tolosa, Eduardo" uniqKey="Tolosa E" first="Eduardo" last="Tolosa">Eduardo Tolosa</name><affiliation wicri:level="1"><nlm:affiliation>Neurology Service, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Hospital Clínic, IDIBAPS, Universitat de Barcelona, Catalonia, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Neurology Service, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Hospital Clínic, IDIBAPS, Universitat de Barcelona, Catalonia</wicri:regionArea><wicri:noRegion>Catalonia</wicri:noRegion></affiliation></author></analytic><series><title level="j">Parkinsonism & related disorders</title><idno type="e-ISSN">1873-5126</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cohort Studies</term><term>Double-Blind Method</term><term>Female</term><term>Humans</term><term>Indans (therapeutic use)</term><term>Male</term><term>Motor Activity (drug effects)</term><term>Neuroprotective Agents (therapeutic use)</term><term>Parkinson Disease (drug therapy)</term><term>Parkinson Disease (physiopathology)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Indans</term><term>Neuroprotective Agents</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Motor Activity</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Cohort Studies</term><term>Double-Blind Method</term><term>Female</term><term>Humans</term><term>Male</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The ADAGIO study included a large cohort of patients with early PD (baseline total-UPDRS = 20) who were initially randomized to rasagiline and placebo, thereby allowing analyses of symptomatic efficacy.</div></front></TEI><affiliations><list><country><li>Espagne</li><li>Israël</li><li>États-Unis</li></country><region><li>Texas</li></region><settlement><li>Houston</li></settlement><orgName><li>Baylor College of Medicine</li></orgName></list><tree><country name="États-Unis"><region name="Texas"><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name></region></country><country name="Israël"><noRegion><name sortKey="Berkovich, Elijahu" sort="Berkovich, Elijahu" uniqKey="Berkovich E" first="Elijahu" last="Berkovich">Elijahu Berkovich</name></noRegion><name sortKey="Eyal, Eli" sort="Eyal, Eli" uniqKey="Eyal E" first="Eli" last="Eyal">Eli Eyal</name></country><country name="Espagne"><noRegion><name sortKey="Tolosa, Eduardo" sort="Tolosa, Eduardo" uniqKey="Tolosa E" first="Eduardo" last="Tolosa">Eduardo Tolosa</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/JankovicV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000055 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000055 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= JankovicV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:24637126
|texte= Symptomatic efficacy of rasagiline monotherapy in early Parkinson's disease: post-hoc analyses from the ADAGIO trial.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:24637126" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a JankovicV1
| This area was generated with Dilib version V0.6.19. |  |